Repligen Corp (RGEN) News
Latest headlines that mention RGEN, newest first · each headline opens the original publisher
- Last price
- $180.01
- Day change
- +0.63%
- Next earnings
- 2026-10-27 BMO
RGEN headlines
latest coverageBiolife Solutions Inc. has attracted takeover interest from parties including diagnostics company Repligen Corp., according to people with knowledge of the matter.
RGEN news alerts
Get an alert by email or push when a new headline mentions RGEN.
More news
News headlines aggregated from third-party publishers via public RSS feeds and tagged with the tickers they mention. Frenzy Capital does not publish or endorse the content; clicking a headline opens the original publisher in a new tab.